Gene · 273
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes. | Antibodies (Basel) | 2023 | 37606434 | PubTator, text mining | PubMed |
| Cerebellar Progressive Multifocal Leukoencephalopathy Mimicking Anti-Yo-Antibody-Associated Rapidly Progressive Cerebellar Syndrome. | Neurol Int | 2023 | 37606392 | PubTator, text mining | PubMed |
| Engagement of intrinsic disordered proteins in protein-protein interaction. | Front Mol Biosci | 2023 | 37583961 | PubTator, text mining | PubMed |
| Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure. | JHEP Rep | 2023 | 37583946 | PubTator, text mining | PubMed |
| Mimics of Autoimmune Encephalitis: Validation of the 2016 Clinical Autoimmune Encephalitis Criteria. | Neurol Neuroimmunol Neuroinflamm | 2023 | 37582614 | PubTator, text mining | PubMed |
| Imaging-negative CV2/collapsin response mediator protein 5 antibody-related paraneoplastic myelopathy: a rare and challenging diagnosis. | Quant Imaging Med Surg | 2023 | 37581070 | PubTator, text mining | PubMed |
Autoimmune Encephalitis with Antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the Course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes. | Diagnostics (Basel) | 2023 | 37568953 | PubTator, text mining | PubMed |
| Generalized Polyspike Pattern in EEG Due to Aseptic Meningoencephalitis. | Diagnostics (Basel) | 2023 | 37568932 | PubTator, text mining | PubMed |
| Adipose tissue coregulates cognitive function. | Sci Adv | 2023 | 37566655 | PubTator, text mining | PubMed |
| Amphiphysin-IgG autoimmune sciatic neuropathy and facial neuropathy related to primary central nervous system lymphoma: A case report. | J Neuroimmunol | 2023 | 37556888 | PubTator, text mining | PubMed |
| Transcriptome sequencing reveals novel molecular features of SLE severity. | Front Genet | 2023 | 37554401 | PubTator, text mining | PubMed |
| Targeted down-regulation of Hipp1 ameliorates tau-induced deficits in Drosophila melanogaster. | Genes Dis | 2023 | 37554213 | PubTator, text mining | PubMed |
| Utility of Protein Microarrays for Detection of Classified and Novel Antibodies in Autoimmune Neurologic Disease. | Neurol Neuroimmunol Neuroinflamm | 2023 | 37550073 | PubTator, text mining | PubMed |
| Proteomic insight into human directed selection of the domesticated chicken Gallus gallus. | PLoS One | 2023 | 37549140 | PubTator, text mining | PubMed |
| Progressive encephalomyelitis with rigidity and myoclonus (PERM) associated with anti-glycine receptor antibodies and urothelial carcinoma: a case report. | J Med Case Rep | 2023 | 37533037 | PubTator, text mining | PubMed |
| Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature. | Ther Adv Neurol Disord | 2023 | 37529719 | PubTator, text mining | PubMed |
| Assessment of disease severity and patient prognosis in anti-GABABR encephalitis with and without comorbid tumors. | Front Neurol | 2023 | 37528858 | PubTator, text mining | PubMed |
| Phosphoinositides and intracellular calcium signaling: novel insights into phosphoinositides and calcium coupling as negative regulators of cellular signaling. | Exp Mol Med | 2023 | 37524877 | PubTator, text mining | PubMed |
| Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer's disease. | Front Pharmacol | 2023 | 37521457 | PubTator, text mining | PubMed |
| Two case reports and a systematic review of the literature on adult cerebral cortical encephalitis with anti-myelin oligodendrocyte glycoprotein antibody. | Front Immunol | 2023 | 37520572 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/273/papers?page=10